|
|
|
|
|
|
[¼ö»ó]°¡Å縯ÀÇ´ë º´¸®Çб³½Ç Á¤Âù±Ç ±³¼ö, ¼¼Æ÷º´¸®ÇÐȸ Çмú´ë»ó |
|
|
|
°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø º´¸®°ú Á¤Âù±Ç ±³¼ö°¡ ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦12ȸ Çмú´ë»óÀ» ¼ö»óÇÏ´Â ¿µ¿¹¸¦ ¾È¾Ò´Ù. Á¤Âù±Ç ±³¼ö´Â ÃÖ±Ù ¿¸° ÇÐȸ Ãá°èÇмú´ëȸ¿¡¼ ¡®°©»ó»ù À¯µÎ¾ÏÁ¾ÀÇ Ã¼¸ð¾ç-¿Àµð¸ð¾ç º¯ÇüÀÇ ¼¼Æ÷ÇÐ ¹× ÀÓ»óº´¸®ÇÐÀû Ư¼º°ú CTNNB1 ¹× BRAF À¯ÀüÀÚ µ¹¿¬º¯ÀÌ ºÐ¼®(The cytological, clinical, and pathological features of the cribriform-morular variant of papillary thyroid carcinoma and mutation analysis of CTNNB1 and BRAF genes)'À̶ó´Â ³í¹®À¸·Î ´ë»óÀ» ¼ö»óÇß´Ù.
|
|
|
|
|
|
|
|
|
|
|